Antibiotics used to treat bacterial infections that affect many different parts of the body. First introduced in the United States in the 1980s, fluoroquinolones such as ciprofloxacin work by killing bacteria or preventing their growth. They are powerful antibacterials with broad-spectrum activity able to treat infections of bones and joints and infections in the respiratory, genital, and gastrointestinal tracts.
A class of antimicrobial agents that kill bacteria by inhibiting their DNA gyrase and topoisomerase enzymes. Antibiotics of this class include ciprofloxacin, levofloxacin and moxifloxacin.
A relatively recent class of antibiotics that has exhibited promising effectiveness in treating infections caused by various gram-negative bacteria, including Shigella. However, a limitation of these antibiotics is their incompatibility with children under the age of 17 due to potential impacts on bone and cartilage growth.